Cocrystal Pharma Inc COCP:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 05/17/24 EDT
1.95quote price arrow down-0.02 (-0.76%)
Volume
8,001
52 week range
1.33 - 3.29
Loading...
  • Open1.90
  • Day High2.07
  • Day Low1.80
  • Prev Close1.97
  • 52 Week High3.29
  • 52 Week High Date08/10/23
  • 52 Week Low1.33
  • 52 Week Low Date02/20/24

Key Stats

  • Market Cap19.839M
  • Shares Out10.17M
  • 10 Day Average Volume0.00M
  • Dividend-
  • Dividend Yield-
  • Beta1.35
  • YTD % Change13.23

KEY STATS

  • Open1.90
  • Day High2.07
  • Day Low1.80
  • Prev Close1.97
  • 52 Week High3.29
  • 52 Week High Date08/10/23
  • 52 Week Low1.33
  • 52 Week Low Date02/20/24
  • Market Cap19.839M
  • Shares Out10.17M
  • 10 Day Average Volume0.00M
  • Dividend-
  • Dividend Yield-
  • Beta1.35
  • YTD % Change13.23

RATIOS/PROFITABILITY

  • EPS (TTM)-1.90
  • P/E (TTM)-1.03
  • Fwd P/E (NTM)-0.95
  • EBITDA (TTM)-20.963M
  • ROE (TTM)-54.54%
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-2,351.57%
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date08/12/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Cocrystal Pharma Inc

 

Profile

MORE
Cocrystal Pharma, Inc. is a clinical-stage biotechnology company. The Company is engaged in discovering and developing novel antiviral therapeutics that target the replication process of influenza viruses, coronaviruses (including SARS-CoV-2), noroviruses and hepatitis C viruses (HCV). It is developing small molecule antiviral therapeutics that inhibit the essential viral replication function of RNA viruses causing acute and chronic viral diseases. It has several candidates...
Roger Kornberg Ph.D.
Chairman of the Board
Sam Lee Ph.D.
President, Co-Interim Chief Executive Officer
Address
19805 N Creek Pkwy
Bothell, WA
98011-8251
United States

Top Peers

SYMBOLLASTCHG%CHG
GLYC
GlycoMimetics Inc
0.2994+0.0183+6.5101%
GLTO
Galecto Inc
0.6211-0.0089-1.4127%
NERV
Minerva Neurosciences Inc
2.52-0.05-1.90%
ALZN
Alzamend Neuro Inc
0.6336-0.0154-2.3729%
EVAX
Evaxion Biotech A/S
3.72-0.11-2.87%